日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study

皮下注射Lenacapavir治疗多重耐药HIV-1感染者:CAPELLA研究的156周结果

Ogbuagu, Onyema; Wiznia, Andrew; McGowan, Joseph P; Berger, Daniel S; Creticos, Catherine M; Hagins, Debbie; Hodge, Theo; Osiyemi, Olayemi; Sims, James; Wheeler, David A; Wang, Hui; Margot, Nicolas A; Dvory-Sobol, Hadas; Rhee, Martin S; Segal-Maurer, Sorana; Molina, Jean-Michel

Professional dancers' beliefs and conceptualisations of their posture and movement: A qualitative research study

专业舞者对其姿势和动作的信念和概念化:一项定性研究

Guo, Andi; Zhang, Xiao; Hagins, Marshall; Liederbach, Marijeanne; Hodges, Paul W

DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain

DEFINE:一项前瞻性、随机、4期临床试验,旨在评估基于蛋白酶抑制剂的方案转换策略在控制整合酶抑制剂相关体重增加方面的疗效。

Anderson, David; Ramgopal, Moti; Hagins, Debbie P; Lee, Johnnie; Simonson, Richard Bruce; Hsu, Tien-Huei; Xu, Ping; Ahmad, Nina; Short, William R

Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV

HIV 患者长期使用含比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺或多替拉韦的方案治疗后,其代谢变化情况如何?

Daar, Eric S; Orkin, Chloe; Sax, Paul E; Hagins, Debbie; Pozniak, Anton; Workowski, Kimberly; Brinson, Cynthia; Tiraboschi, Juan Manuel; Liu, Hui; Deaton, Chris; Cohen, Cal; Madera, Sharline; Hindman, Jason T; Ramgopal, Moti

Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV-1 initiating first-line therapy: 5-year follow-up from two phase III studies

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺在接受一线治疗的黑人和西班牙裔/拉丁裔 HIV-1 感染成人中的疗效和安全性:两项 III 期研究的 5 年随访结果

Martorell, C; Ramgopal, M; Hagins, D; Osiyemi, O; Arribas, J R; Berhe, M; Yazdanpanah, Y; Orkin, C; Santiago, L; Rosero, C; Unger, N; Liu, H; Rogers, R; Hindman, J T; Wurapa, A

Establishing the contribution of active histone methylation marks to the aging transcriptional landscape of Drosophila photoreceptors

确定活性组蛋白甲基化标记对果蝇光感受器衰老转录景观的贡献

Juan Jauregui-Lozano, Sarah E McGovern, Kimaya M Bakhle, Arrianna C Hagins, Vikki M Weake

1985. A Prospective, Randomized Trial to Assess a Protease Inhibitor–based Regimen Switch Strategy to Manage Integrase Inhibitor–related Weight Gain

1985年。一项前瞻性随机试验,旨在评估基于蛋白酶抑制剂的方案转换策略在控制整合酶抑制剂相关体重增加方面的疗效。

Serna-Galvis, Efraím A; Arboleda-Echavarría, Johana; Echavarría-Isaza, Adriana; Torres-Palma, Ricardo A; Coutinho, Eulalia A; Fowler, Melissa A; Regan, Collin; Zhao, Jian; Fleck, Beth A; Boekell, Kimber; Tang, Yang; Rico-Bautista, Elizabeth; Woeller, Collynn F; Feldon, Steven E; Dalvie, Deepak; Betz, Stephen F; Bakker, T R; Briasoulis, O; Olivieri, A; Pain, S; Palagini, L; Kunz, D; Geoffroy, P-A; Daigle, Denis; Hamrick, Jodie; Chatwin, Cassandra; Kurepina, Natalia; Kreiswirth, Barry N; Shields, Ryan K; Oliver, Antonio; Clancy, Cornelius J; Nguyen, Minh-Hong; Pevear, Daniel; Xerri, Luigi; Short, William R; Ramgopal, Moti; Hagins, Debbie P; Lee, Johnnie; Bruce Simonson, Richard; Hsu, Tien-Huei; Xu, Ping; Anderson, David

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals

HIV-1 附着抑制剂前药福斯特沙韦在重度治疗经验患者中的 III 期 BRIGHTE 试验的患者报告结果

Anderson, Sarah-Jane; Murray, Miranda; Cella, David; Grossberg, Robert; Hagins, Debbie; Towner, William; Wang, Marcia; Clark, Andrew; Pierce, Amy; Llamoso, Cyril; Ackerman, Peter; Lataillade, Max

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study

在感染 HIV-1 的黑人美国人中改用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺:一项随机 3b 期、多中心、开放标签研究

Hagins, Debbie; Kumar, Princy; Saag, Michael; Wurapa, Anson K; Brar, Indira; Berger, Daniel; Osiyemi, Olayemi; Hileman, Corrilynn O; Ramgopal, Moti N; McDonald, Cheryl; Blair, Christiana; Andreatta, Kristen; Collins, Sean E; Brainard, Diana M; Martin, Hal

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials

从利匹韦林 (RPV)、恩曲他滨 (FTC) 和富马酸替诺福韦二吡呋酯 (TDF) 或依非韦伦、FTC 和 TDF 转换为利匹韦林 (RPV)、恩曲他滨 (FTC) 和替诺福韦艾拉酚胺复方制剂:两项随机临床试验的 96 周结果

Hagins, D; Orkin, C; Daar, E S; Mills, A; Brinson, C; DeJesus, E; Post, F A; Morales-Ramirez, J; Thompson, M; Osiyemi, O; Rashbaum, B; Stellbrink, H-J; Martorell, C; Liu, H; Liu, Y-P; Porter, D; Collins, S E; SenGupta, D; Das, M